Health ❯ Clinical Research

Drug Development

Clinical Trials Cancer Therapies Preclinical Studies Regulatory Approval FDA Approval Monoclonal Antibodies Ezogabine Phase 3 Trials Chimeric Peptides Mechanism of Action Targeted Therapy Nektar Therapeutics Antifungal Research mRNA Innovations FDA Regulations Personalized Medicine Anti-inflammatory Medications Patient Trials Regulatory Agencies Antibody Therapy Accelerated Approval Cancer Drugs Phase Trials Therapeutic Applications Experimental Treatments Gender Differences Repurposing Drugs

Cholera-Derived Toxin Slows Colorectal Tumors in Mice, Rewiring Local Immunity

Researchers report tumor-targeted activity with safety signals in mouse models using the purified cytotoxin MakA.

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial

Liverpool Researchers Report Novltex, a Synthetic Antibiotic Class Against Multidrug-Resistant Bacteria

Novartis to Acquire Tourmaline Bio for $1.4 Billion to Bolster Heart-Drug Pipeline

Terasaki Researchers Debut Human Liver Tumor ‘Embolization-on-a-Chip’ for Embolic Therapy Testing

Autism-Like Behaviors in Mice Traced to Thalamic Circuit as Epilepsy Drug Candidate Reverses Signs

Nektar Therapeutics’ Rezpegaldesleukin Trial Success Sends Shares Up 150%

Acetaminophen Metabolite AM404 Targets Peripheral Nerves to Relieve Pain

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer

New Studies Highlight Ezogabine’s Potential to Redefine Depression Treatment